CV Lattes
ORCID
Google Scholar Citations
Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE). Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduated in Medical Sciences from the Catholic University of São Paulo (2002). Medical Residency in Infectious Diseases, Institute of Infectious Diseases Emilio Ribas (2005). Formation Spécialisée approfondie, Maladies Infectieuses, Université de Versailles Saint-Quentin-en-Yvelines (2006). Specialization in Hospital-Infection, University of São Paulo (2007). Medical Microbiology Laboratory Assistant, Central Laboratory Department, Hospital das Clinicas, Faculty of Medicine, University of São Paulo. Doctorate from the Faculty of Medicine, University of São Paulo (2014). Specialization course in Medical Mycology at Institut Pasteur in Paris (2015). Post-doctorate, School of Medicine, University of São Paulo (2017). Clinical Pathology specialist (2022). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Invasive fungal infections (IFIs) are an increasingly common problem in immunocompromised patients. Its high mortality is related to several factors, but the severity of the underlying diseases, which predisposes the patient to invasive mycoses, to late or erroneous diagnosis of IFIs, deserves to be highlighted. Technological advances with more accurate diagnostic tools may help to diagno…
Factors such as the use of invasive devices, wide-spectrum antimicrobials and immunosuppressors are responsible for infections by rare pathogens that may be associated with high morbidity and mortality. The species of Candida haemulonii complex are emerging pathogens that are still poorly studied in the country. Isolates with resistance to fluconazole and amphotericin were described.Since…
Trichosporon asahii is an emergent agent of invasive infection in immunocompromised hosts and patients with invasive disposals. Azoles are the best therapeutic approach for treating invasive trichosporonosis, but epidemiological and microbiological data obtained by the Brazilian Trichosporon Network documented T. asahii from deep-seated infections with high MICs against fluconazole (>32mg…
| 1 / 1 | Ongoing grants |
| 1 / 1 | Completed research grants |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All research grants and scholarships |
| Associated processes | |